KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cvs Health (CVS) Net Income towards Common Stockholders (2016 - 2025)

Cvs Health (CVS) has disclosed Net Income towards Common Stockholders for 17 consecutive years, with $2.9 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Income towards Common Stockholders rose 80.1% year-over-year to $2.9 billion, compared with a TTM value of $1.7 billion through Dec 2025, down 62.32%, and an annual FY2025 reading of $1.7 billion, down 62.32% over the prior year.
  • Net Income towards Common Stockholders was $2.9 billion for Q4 2025 at Cvs Health, up from -$4.0 billion in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $2.9 billion in Q2 2022 and bottomed at -$4.0 billion in Q3 2025.
  • Average Net Income towards Common Stockholders over 5 years is $1.3 billion, with a median of $1.8 billion recorded in 2021.
  • The sharpest move saw Net Income towards Common Stockholders skyrocketed 166.4% in 2023, then tumbled 5719.72% in 2025.
  • Year by year, Net Income towards Common Stockholders stood at $1.4 billion in 2021, then skyrocketed by 68.13% to $2.3 billion in 2022, then fell by 12.22% to $2.0 billion in 2023, then decreased by 20.71% to $1.6 billion in 2024, then soared by 80.1% to $2.9 billion in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for CVS at $2.9 billion in Q4 2025, -$4.0 billion in Q3 2025, and $1.0 billion in Q2 2025.